Cardiff Oncology Inc (CRDF) News

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

- First patient dosed in Phase 2 first-line trial in patients with RAS-mutated mCRC for new lead program with...

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC

- New clinical data from second-line randomized ONSEMBLE trial provides further evidence of the efficacy of...

Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)

- Phase 2 trial in patients with RAS-mutated mCRC will evaluate onvansertib plus SoC versus SoC alone in the...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1...

Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update

- Management will hold a conference call on Thursday, February 29 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research

Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in...

Form 8-K - Current report

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference PR Newswire SAN DIEGO, Nov...

Form 8-K - Current report

Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update

Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update PR Newswire SAN DIEGO, Nov...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update

Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update PR Newswire SAN...

Form 8-K - Current report